Epilepsies in children, young people and adults

This is an update to NICE guideline NG217 (published April 2022 and previously updated January 2025).

We are reviewing recommendations 6.4.2 to 6.4.4 in section 6.4 on self-limited epilepsy with centrotemporal spikes. We are in the process of:

• reviewing the licensed status for treatments recommended for self-limited epilepsy with centrotemporal. spikes including the UK licencing approval of sultiame in January 2025.
• searching for any new evidence on treatments for self-limited epilepsy with centrotemporal spikes.
• we have appointed an expert working group to advise on any changes to recommendations.
• we will consult on any proposed changes.